15 results about "Active treatment" patented technology

The invention discloses an active treatment method for multi-source residual coal gas of a waste mine, which comprises the following steps: firstly, hydraulic fracturing pressure relief permeability improvement and overlying strata separation layer grouting reinforcement are cooperated, the hydraulic fracturing pressure relief permeability improvement establishes a netted fracture network in a coal body to realize permeability improvement, and the overlying strata separation layer grouting reinforcement compacts goaf gangue through grouting and reinforces an overlying strata to form a continuous bearing consolidation body; and therefore, a pressure relief and permeability increasing-strengthening and reinforcing integrated structure is formed, a stable structure and a penetrating seepage network are provided for subsequent displacement and gas extraction, and the subsequent gas extraction efficiency is guaranteed. Then low-temperature liquid CO2 is injected into the coal seam through the injection well, gas displacement and desorption are conducted on gas adsorbed in the coal seam under the action of phase change and competitive adsorption, expansion and development are conducted on fractures to enable permeability to be secondarily enhanced, and meanwhile part of CO2 obtained after displacement is retained and sealed in a coal body and a goaf; on the premise that the gas extraction concentration and efficiency are effectively improved, CO2 can be stored, and the dual effects of resource utilization and carbon storage are achieved.

A biocompatible medical device can be at least partially implantable into a living human or animal subject to provide active treatment of biofilm that can occur use within the subject. The medical device can include a catheter, including an interior conduit capable of permitting fluid flow. A heating device can be located on a portion of the catheter to be located within the subject, the heating device including at least a pair of electrodes having a variable spacing therebetween, the variable spacing specified to allow heat to be generated using a time-varying electromagnetic input signal providing a variable frequency to control a variable location along the electrodes at which heat is generated, such as can provide a virtual matrix of local heat sources.

To provide an active treatment agent for laver aquaculture containing oxalic acid dihydrate.SOLUTION: The present invention relates to an active treatment agent for laver aquaculture containing oxalic acid dihydrate, wherein a first active treatment agent containing oxalic acid dihydrate is superior in pitch removal capability, green laver removal capability, copepod removal capability, and cadmium removal capability, and, when mixed with a second active treatment agent that is activated chlorine dioxide aqueous solution, by confirming that harmful microorganisms belonging to the genus Pseudoalteromonas, which soften laver tissue, are markedly reduced, an active treatment agent for laver aquaculture that is environmentally friendly and excellent is provided.SELECTED DRAWING: Figure 1

The utility model provides a kind of to prevent and cure phlebitis indwelling needle patch with drug sustained release and observation window, including indwelling needle patch body, the indwelling needle patch body includes film baseband, bottom layer anti-adhesion release paper, circular puncture observation window and drug sustained release layer, the film baseband is divided into film baseband front side area and film baseband rear side area, and film baseband front side and film baseband rear side are fixed on bottom layer anti-adhesion release paper, and the surface edge of film baseband is fixed with frame film holding.The patch is integrated by drug sustained release and incision etc., and passive protection is changed into active treatment, fills the technical blank of existing patch in phlebitis prevention, with significant clinical practical value.Through drug sustained release technology, integrated fixing structure and modular design, realize the comprehensive promotion of phlebitis prevention, indwelling needle stable fixation and patient comfort.The film baseband is longer than traditional indwelling needle patch length, and can be conveniently torn down and replaced.

According to one aspect of the present invention, an oncolytic adenovirus vector for cancer treatment encoding at least TNFα and / or IL-2 is provided. The adenovirus vector is administered to a subject at least three times, preferably at least five, six, or seven times, in an active treatment cycle, with at least one administration, preferably the first, being systemic, and the active treatment cycle preferably does not include the administration of adoptive cell therapeutic compositions containing TIL or the administration of immune checkpoint inhibitors.

A light treatment device that treats a subject with light of multiple wavelengths to provide beneficial treatment effects. The device may emit at least three different wavelengths selected from specific combinations of wavelengths that have been found to have a synergistic and positive therapeutic effect. The lamp may be incorporated into any type of treatment device, such as a handheld light treatment device, a light treatment element integrated into a hat for treating scalp or for alopecia, a light treatment couch, a light treatment facial treatment device, and a light treatment sauna room.

An active treatment formulation for application to a substrate, and a skin treatment article comprising the active treatment formulation applied to the substrate. The active treatment formulation comprises an activator and a water-soluble binder. The activator may be mixed with an absorbent powder, encapsulated in solid form by a encapsulating material, or chemically modified in solid form. In exemplary embodiments, the active treatment formulation for application to a substrate comprises an activator mixed with or combined with a water-soluble binder to form the active treatment formulation.

The invention relates to an anti-depression compound 4-methyl-6-methoxy coumarin, and belongs to the technical field of biological medicines. Depression is the most common mental disorder in the world and is also a main reason for disability. The development of a novel anti-depression drug which is based on a nerve plasticity mechanism, takes effect quickly, has a lasting curative effect and is high in safety, and particularly has important clinical requirements and technical necessity for an effective treatment means for refractory depression. Traditional Chinese medicine monomers and a per2- / -zebra fish depression model are adopted for anti-depression drug screening, and finally it is found that 10 mM of 4-methyl-6-methoxycoumarin has the anti-depression characteristic and has the positive treatment effect on the exploration behavior, social interaction and sleep-awakening period of per2- / -zebra fish. The method can effectively rescue and reverse depression-like phenotypes observed in a per2- / -zebra fish circadian rhythmic depression model, and can restore the balance of important gene expression.

The invention discloses a new energy grid-connected point power quality disturbance traceability and active treatment method and system, and belongs to the technical field of power system power quality monitoring and treatment. Comprising the following steps: establishing a multi-stage monitoring network covering new energy grid-connected points, key buses and sensitive load nodes, and synchronously extracting local electric energy quality index feature vectors by monitoring terminals deployed at the nodes and converging the local electric energy quality index feature vectors to a central master station; the central master station calculates the disturbance correlation degree between the nodes based on the converged data by fusing the electrical distance weight and the characteristic time sequence correlation, identifies a high-correlation-degree node cluster by adopting a community discovery algorithm, and intelligently deduces the most probable disturbance source node and the characteristic portrait thereof by combining with multi-dimensional criteria such as time sequence leading and electrical centrality; and according to a tracing result, matching an optimal strategy from a preset treatment strategy knowledge base, automatically generating and issuing a layered and differentiated collaborative treatment instruction aiming at the disturbance source node, the adjacent treatment device and the influenced load, and realizing closed-loop active treatment from disturbance perception to accurate suppression.

The application relates to the technical field of coal mine roadway supporting, and discloses a comprehensive active treatment method and device for coal mine roadway floor heave, which comprises the following steps: installing anchor rods and cables on the roadway roof and two sides, and excavating a compensation groove in the middle of the floor stratum; placing a pi-shaped prestressed steel beam in the groove, applying mechanical tension to the steel beam through a tensioning device, and expanding and pressing the side wall rock mass on both sides of the steel beam; then, injecting a micro-expansion cement-based grouting material into the groove; and after the grouting material is solidified to form a high-strength grouting body, releasing the tension, and transferring the prestress to the grouting body and the floor stratum. The application releases the concentrated stress in the shallow part of the floor, establishes a combined bearing structure composed of the prestressed steel beam and the grouting body in the shallow part of the floor, changes the floor rock mass into a three-way compression state, provides downward resistance bending moment, and controls the deformation of the roadway floor heave.

In accordance with example aspects of the invention, there is provided the use of an oncolytic adenoviral vector encoding at least TNF [alpha] and / or IL-2 for the treatment of cancer wherein the adenoviral vector is administered to a subject at least three times, preferably at least 5, 6 or 7 times over a positive treatment cycle; and wherein at least one, preferably the first, administration is systemic administration wherein the positive treatment cycle preferably does not comprise administration of an adoptive cell therapeutic composition comprising TIL or does not comprise administration of an immune checkpoint inhibitor.

The invention relates to a ventilation mask and breathing equipment, and relates to the technical field of ventilation treatment. According to the ventilation mask, a magnetic field recognition device is arranged in the ventilation mask, the magnetic field recognition device is located on the side, close to a patient, of the ventilation mask or the side, away from the patient, of the ventilation mask, and the magnetic field recognition device is constructed to be capable of recognizing at least one magnetic field. The magnetic field recognition device arranged in the ventilation mask can recognize a magnetic field, so that the ventilation mask can be applied to a clinical nuclear magnetic environment; and the ventilation mask is worn on the face of the patient, so that the ventilation mask and the magnetic field recognition device are closer to the patient compared with active treatment equipment such as a breathing machine, and a better magnetic field recognition position can be obtained.

The invention relates to a wearable system integrating artificial intelligence and active treatment, which comprises three breakthrough designs: 1, a bimodal sensing network: constructing a distributed biological signal acquisition matrix by adopting a laser-engraved graphene electrocardio-electrode (the signal-to-noise ratio is greater than or equal to 120dB) and an MXene / hydrogel composite body temperature sensor (the precision is + / -0.1 DEG C); 2, a double-loop intelligent center: an early warning loop: analyzing electrocardio and body temperature associated characteristics in real time based on a deep residual network (ResNet-1D), and predicting a heat stroke risk; the treatment loop is integrated with a semiconductor chilling plate and a microneedle medicine slow release unit to realize'early warning-intervention 'closed-loop response; 3, edge-cloud collaborative architecture: multi-terminal data synchronization is realized through a 5G slicing technology, and delay lt is responded; and 15ms. Through actual measurement of national cross-country ski teams, the high-risk event recognition rate is 99.2%, the treatment starting speed is increased by 8 times compared with that of a traditional means, and the method can be expanded to the fields of fire fighting and military affairs.

The invention provides a nursing pharmaceutical composition for preventing pressure sores and a preparation method thereof, and the composition is composed of an active component, a liquid absorption component and pharmaceutically acceptable auxiliary materials, active components of the composition comprise an astragalus extract, an angelica sinensis extract, a lithospermum extract, a recombinant human epidermal growth factor, pentoxifylline, polyhexamethylene biguanide hydrochloride, beta-glucan, asiaticoside and magnolol, and the effects of improving microcirculation, resisting inflammation and bacteria and promoting tissue repair are comprehensively achieved through a multi-target synergistic effect; luminan microspheres or calcium alginate fibers are adopted as liquid absorption components, wound exudate is effectively managed, a wet environment is maintained, a split-phase preparation and low-temperature integration process is adopted in the preparation method, the compatibility problem of complex components is solved, and the stability and effectiveness of the product are ensured; the device integrates active treatment and protection, is suitable for preventing and treating pressure sores in all stages, and has the advantages of being remarkable in effect and safe to use.

The invention provides exudate responsive self-shedding core-shell microgel powder for burn and scald wounds and a preparation method of the exudate responsive self-shedding core-shell microgel powder, and belongs to the technical field of medical materials. The core-shell microgel powder provided by the invention can quickly absorb a large amount of exudate after being applied to a wound surface and form attached hydrogel in situ, so that an ideal wet environment and physical protection are provided for wound surface healing; due to the percolate response characteristic, active ingredients can be intelligently released to actively regulate and control inflammation and promote repair, mild self-falling of the dressing can be achieved in the later period of healing, and the patient experience and treatment compliance are greatly improved. According to the product, efficient seepage management, active treatment intervention and humanized painless removal are combined, and a brand-new and integrated solution is provided for clinical nursing of complex seepage wounds such as burns and scalds.